# Argenx SE: Form 20-F for the period ended Dec 31, 2022

- Company: [Argenx SE](/companies/argx.md) (CIK 1697862)
- Form: 20-F
- Filed: 2023-03-16
- Accepted by EDGAR: Mar 16, 2023, 16:26 ET
- Period: 2022-12-31
- Accession: 0001558370-23-004027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1697862/000155837023004027/argx-20221231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1697862/000155837023004027/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | $10.0m | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months, 2022-01-01 to 2022-12-31 | $29.4m | ifrs-full:CostOfSales |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | −$720.3m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | −$19.7m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | −$709.6m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | −$13.05 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | −$13.05 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | −$862.8m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $837.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2022-12-31 | $800.7m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2022-12-31 | $2.77bn | ifrs-full:CurrentAssets |
| Total assets | at 2022-12-31 | $3.13bn | ifrs-full:Assets |
| Current liabilities | at 2022-12-31 | $302.3m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2022-12-31 | $320.6m | ifrs-full:Liabilities |
| Shareholders' equity | at 2022-12-31 | $2.81bn | ifrs-full:Equity |
| Shares outstanding | at 2022-12-31 | 55,395,856 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1697862/000155837023004027/argx-20221231x20f.htm

Filed Mar 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-004027. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.